user

Chemotherapy of increasing intensity in the treatment of chronic myelomonocytic leukemia (CMML).

被引：0
|
作者：
Beran, M [1 ]
Onida, F [1 ]
Cortes, JE [1 ]
O'Brien, S [1 ]
Giles, FJ [1 ]
Estey, E [1 ]
Keating, MJ [1 ]
Koller, CA [1 ]
Kantarjian, HM [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2614
引用
收藏
页码：624A / 624A
页数：1
相关论文
共 50 条
  • [41] A Close Association of History of Autoimmunity with Chronic Myelomonocytic Leukemia (CMML) in Contrast to Chronic Myelogenous Leukemia (CML)
    Peker, Deniz
    Padron, Eric
    Horna, Pedro
    Bennett, John M.
    Zhang, Xiaohui
    Epling-Burnette, P. K.
    Lancet, Jeffrey E.
    Pinilla, Javier
    Moscinski, Lynn
    List, Alan F.
    Komrokji, Rami S.
    Zhang, Ling
    BLOOD, 2012, 120 (21)
  • [42] Risk-Adapted, Individualized Treatment Strategies of Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)
    Bewersdorf, Jan Philipp
    Zeidan, Amer M.
    CANCERS, 2021, 13 (07)
  • [43] Treatment of chronic myelomonocytic leukemia
    Burgstaller S.
    memo - Magazine of European Medical Oncology, 2016, 9 (4) : 168 - 171
  • [44] A Comparison of Prognostic Models for Chronic Myelomonocytic Leukemia (CMML) in the Era of Hypomethylating Agents
    Padron, Eric
    Al Ali, Najla H.
    Peker, Deniz
    Lancet, Jeffrey E.
    Epling-Burnette, Pearlie K.
    Zhang, Ling
    List, Alan F.
    Komrokji, Rami S.
    BLOOD, 2012, 120 (21)
  • [45] IDIOPATHIC THROMBOCYTOPENIA (ITP)-LIKE PRESENTATION IN CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) AND OUTCOME
    Al-Kali, A.
    Swedeh, A.
    Litzow, M.
    Elliott, M.
    Wolanskyj, A.
    Patnaik, M.
    Begna, K.
    Pardanani, A.
    Hanson, C.
    Tefferi, A.
    Al-Kali, A.
    HAEMATOLOGICA, 2012, 97 : 635 - 635
  • [46] Clinical outcomes and pathological patterns after splenectomy for chronic myelomonocytic leukemia (CMML).
    Steensma, DP
    Tefferi, A
    Li, CY
    BLOOD, 2002, 100 (11) : 338B - 338B
  • [47] Decitabine induces high response rates in patients with chronic myelomonocytic leukemia (CMML).
    Jabbour, Elias
    O'Brien, Susan
    Ravandi-Kashani, Farhad
    Cortes, Jorge
    Borthakur, Gautam
    Verstovsek, Srdan
    Garcia-Manero, Guillermo
    Giles, Francis
    Zanoria, Lourdes
    Davisson, Jan
    Issa, Jean-Pierre
    Kantarjian, Hagop M.
    BLOOD, 2006, 108 (11) : 750A - 750A
  • [48] Effect of obesity on overall survival in patients diagnosed with chronic myelomonocytic leukemia (CMML)
    Alfakara, Dima
    Swedeh, Amer
    Kaufman, Gregory
    Patnaik, Mrinal M.
    Hashmi, Sharukh
    Hogan, William J.
    Elliott, Michelle A.
    Wolanskyj, Alexandra P.
    Liu, Shujun
    Litzow, Mark Robert
    Al-Kali, Aref
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [49] Generation of immunologically active dendritic cells from chronic myelomonocytic leukemia (CMML).
    Claxton, DF
    Konneh, D
    Champlin, R
    Choudhury, A
    BLOOD, 2000, 96 (11) : 259B - 259B
  • [50] 2006 chronic myelomonocytic leukemia (CMML): The role of bone marrow biopsy immunohistology
    Chiu, R
    O'Malley, DP
    Allen, S
    Czader, M
    Orazi, A
    LABORATORY INVESTIGATION, 2006, 86 : 219A - 219A
12345